Publication | Closed Access
Beneficial effects of MET-88, a γ-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction
28
Citations
39
References
2000
Year
CardiomyopathyHeart FailureCardiovascular DiseaseBiochemistryMedicinePhysiologyCardiovascular PharmacologyPharmacotherapyγ-Butyrobetaine Hydroxylase InhibitorCardiovascular ToxicityPharmacologyCardiologyOxidative StressMyocardial Infarction
| Year | Citations | |
|---|---|---|
Page 1
Page 1